Aclaris Therapeutics JAK Inhibitors

Vixen Pharmaceuticals Acquired By Aclaris Therapeutics

March 28, 2016 /

Well you guys asked for it, right? An established pharmaceutical company has acquired the rights to Angela Christiano’s hair growth research involving JAK inhibitors. Aclaris Therapeutics has entered into an agreement with Vixen to acquire all of the stock of Vixen Pharmaceuticals. For those unaware, Vixen Pharma is the small startup company that Christiano founded…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.